Tus Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tus Pharmaceutical Group Co Ltd with three other
companies in this sector in CHINA :
Zhejiang Xinguang Pharmaceutical Co Ltd
sales of 283.08 million Chinese Renmimbi [US$43.99 million]
of which 76%
was Huangqi Shengmai Drink),
Shenzhen Chipscreen Biosciences Co Ltd
(269.47 million Chinese Renmimbi [US$41.87 million]
of which 100%
was Chidamide), and
Hainan Shuangcheng Pharmaceuticals Co Ltd
(269.44 million Chinese Renmimbi [US$41.87 million]
of which 93%
was Self-made medicine Business).
During the second
quarter of 2021, sales at Tus Pharmaceutical Group Co Ltd totalled
70.09 million Chinese Renmimbi.
an increase of 26.0%
from the 55.64 million Chinese Renmimbi in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 148.51 million Chinese Renmimbi, which is
than through the first two quarters of 2020.
Tus Pharmaceutical Group Co Ltd reported sales of 275.09 million Chinese Renmimbi (US$42.74 million)
December of 2020.
decrease of 12.7%
versus 2019, when the company's sales were 315.03 million Chinese Renmimbi.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Tus Pharmaceutical Group Co Ltd had sales
of 294.72 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 20.9% decline
in Western Medicine Manufacturing, from 25.63 million Chinese Renmimbi to 20.26 million Chinese Renmimbi.
There were also decreases in sales in
Chinese Medicine Healthcare Production (down 12.1% to 253.46 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Other Business (up 12.7% to 1.37 million Chinese Renmimbi)